Cambridge scientists join team exploring the role of senescent (non-growing) cells in childhood brain tumour development and recurrence, in new research funded by The Brain Tumour Charity.
A new clinical trial is being carried out by CRUK’s Centre for Drug Development to evaluate the orally available drug, HTL0039732, for advanced solid tumours.
The new platform, called ‘MN-predict’, will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal cancers.
Cambridge Cancer Research Hospital (CCRH) has had the second stage of its business case, its Outline Business Case, approved by NHS England, the Department of Health and Social Care and HM Treasury.
To mark World Head and Neck Cancer Day on Thursday 27 July, our research and clinical teams ran an information and activity stand in the Oncology Day Unit at Addenbrooke’s.
Our cutting edge cancer research would not be possible without our strong partnership between Cancer Research UK, Cambridge University Hospitals and the University of Cambridge.
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by Professor Charlotte Coles and funded by Cancer Research UK.